Clinical Trials Browser

Completed × OGX-011 × Clear all

NCT01630733 2026-04-15

ENSPIRIT

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00138918 2017-03-03

Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT01188187 2016-10-14

SYNERGY

Phase 3 Completed

Prostatic Neoplasms

NCT01578655 2016-10-12

AFFINITY

Phase 3 Completed

Prostatic Neoplasms

NCT01497470 2016-10-10

A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen

Phase 1 Completed

Neoplasms

NCT01874561 2016-10-10

Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization

Phase 1 Completed

Neoplasms

NCT00327340 2012-10-05

Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC

Phase 2 Completed

70 enrolled 11 charts

Prostatic Neoplasms

NCT00138658 2012-02-06

A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2 Completed

85 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung